Navigation Links
Abbott to Present New Data Across its Vascular Portfolio at the,,,American College of Cardiology's 56th Annual Scientific Session

Highlights Include First U.S. Clinical Data on XIENCE V Everolimus Eluting Coronary Stent System and Six-Month Patient Follow-Up Results from the ABSORB Bioabsorbable Stent Clinical Study

ABBOTT PARK, Ill., March 19, 2007 /PRNewswire-FirstCall/ -- Abbott will present data from several studies across its broad vascular portfolio and pipeline during a number of late-breaking clinical trial and poster sessions at the of Cardiology's 56th Annual Scientific Session being held March 24-27 in New Orleans at the Ernest N. Morial Convention Center.

Late-breaking data presentations from Abbott will include the first U.S. clinical data results from the SPIRIT III pivotal clinical trial comparing the performance at nine months of the XIENCE(TM) V Everolimus Eluting Coronary Stent System to the TAXUS(R) Paclitaxel-Eluting Coronary Stent System; six- month data from ABSORB, the world's first clinical trial of a fully bioabsorbable drug-eluting stent; and interim 30-day data from two studies designed to confirm that carotid stenting can be performed with good results by a variety of physician specialties in real-world (non-clinical trial) settings in patients who are at high risk for carotid artery surgery. In addition, one-year follow-up data on patients enrolled in the SPIRIT II clinical trial will be presented during a poster session.

SPIRIT III Nine-Month Pivotal Clinical Data Results

Late-Breaking Clinical Trials I, i2. Summit Interventional Programming Saturday, March 24, 11:30 a.m. Central Time

Room La Nouvelle Orleans C, Ernest N. Morial Convention Center

Gregg W. Stone, M.D., of Medical Center and the Cardiovascular Research Foundation, New York, will present results from the randomized portion of Abbott's SPIRIT III pivotal clinical trial. SPIRIT III is a large-scale U.S. trial designed to compare Abbott's XIENCE V Evero
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. The Past, Present and Future of HLA Typing
11. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/24/2009)...AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )announced...ealthcareConferenceonTuesday,December1,2009at9:00a...ewYorkPalaceHotel.SteveWorland,Ph.D.,PresidentandC...ofAnadysanditsclinicaldevelopmentprograms,ANA598an...taneouslywebcastandcanbeaccessedontheInvestorRelat...
(Date:11/24/2009)...iontofamily,friendsandhealth,cancersurvivorDianeWi...ratitudelist. ,, "Theyheardthefactsandmadetheju...dictstotaling$103millionindamagesagainstWyethPharm...widewhohavesuedWyethandPfizerpharmaceuticals,maker...kiandtheothervictimsofhormonetherapyhaveallegedinl...
(Date:11/24/2009)...s,Inc.,aprivately-helddeveloperandmarketeroftheVer...nosticsystemformeasuringanindividual,sresponsetomu...n),announcedtodaythatTimothyI.Still,PresidentandCE...OfficerofAccumetrics,willbepresentingacorporateove...cebeingheldinNewYorkCityonDecember1-2,2009atThePal...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 1Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 2Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 3Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 4Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 1Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 2Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 3ACells CEO to Present at Rodman 26 Renshaws 2009 Annual Global Investment Conference 13808 1ACells CEO to Present at Rodman 26 Renshaws 2009 Annual Global Investment Conference 13808 2
...jective response supports expansion of Simon 2-Sta...RANFORD, Conn., June 11 CuraGen Corporation,(Nasd...mpany focused on,oncology, announced today that it...reatment of patients with unresectable Stage III o...for advancement to the second stage,of enrollment....
...une 10 Biopure Corporation,(Nasdaq: BPUR ) today...hopedic trial (HEM-115) have been published in the...per is entitled "HBOC-201 as an Alternative,to Blo...a Multicenter Phase,III Trial in Elective Orthoped...ull through the complex data,repeatedly until insi...
Other Medicine Technology:CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 2CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 3CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 4Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2
(Date:11/24/2009)...ING,Md.,Nov.24/PRNewswire-USNewswire/--Parties,fam...llpartoftheholidaycheer.Butthemerrimentcanchangeto...://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO )...g,diarrhea,andflu-likesymptoms,whichcanstartanywhe...onsumed. ,, "Thegoodnewsisthatpracticingfourbas...
(Date:11/24/2009)...SCO,Nov.24/PRNewswire/--Quantros,aleadinghealthcar...vider,announcedtodaythatithaslicensedintellectualp...tyofMichiganforintegrationintoQuantros,suiteofsafe...iversity,ssoftwarewithintheSRMproductfamilywillena...sthroughutilizationofahealthcareprovider,sintegrat...
(Date:11/24/2009)...h.,Nov.24/PRNewswire/--HealthPlusofMichiganhaslaun...gnedspecificallyforindividuals18to64andtheirfamili...irectly. ,, Thenew HealthPlusSignature plansare...entsandbrokersthroughouttheHealthPlusservicearea.M...vailablebytoll-freephonecallto1-877-562-0907. ,...
(Date:11/24/2009)...lsNewYorkandtheNewYorkStateFraternalOrderofPoliced...iesinPortJervis,NewYork ,, PORTJERVIS,N.Y.,Nov....asterSealsNewYork,inpartnershipwiththeNewYorkState...OutreachatEasterSealsNewYork,sChildDevelopmentCent...dualscametotheoutreachtoreceivefreeturkeys,ham,chi...
(Date:11/24/2009)...en taking sedatives, antidepressants, benzodiazepi...HealthDay News) -- Seniors who take antidepressant...y be at increased risk for falls, a new review sho...d studies that included a total of 79,081 particip...sses of drugs: high blood pressure medicines; diur...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2
... Influenza Campaign to Promote Annual Vaccination ...al Influenza Vaccination Week (December 8-14); Urg..., , CLEVELAND, Dec. 8 Health experts recomme...ry year. Locally, between 23,000 and 95,000 Clevel...
...s the availability,of Trade Alerts on stocks makin...e daily trading notes for free by visiting:, http:...erts include: HCP Inc. (NYSE: HCP ), Healthcare ... NHP ) and National,Health Investors Inc. (NYSE: ...
...0 on 3-Kit Packs;,Opportunity for Families to Star... Mountain View, CA (PRWEB) December 8, 2...sonal genetics, today announced it is offering a ...$70 for every additional kit., , , , ,By offering ...
...12mm AirSeal single incision laparoscopic supracer...ctomy was performed today at Mt. Auburn Hospital i... Rosenblatt performed the procedure through a sing...ot rely on traditional gaskets or valves. This pro...
...macy Outcomes Specialists collaborate to produce s...The Midwest Business Group on Health (MBGH) and Ph...tes for the second annual Pharmacy Benefits Academ...ing Network educational curriculum. The program pr...
...ells, making them easier to spot, study says , ...ance that glows and sticks to viable cancer cells,...ccessfully tested in mice, researchers report. , ...ed on the surface of some breast cancer cells. It ...
Other Medicine News:Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 2Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 3Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 4Health News:Beacon Equity Issues Technical Trade Alerts on REIT Healthcare Facilities: HCP, HR, VTR, UHT, NHP, NHI 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 3Health News:SurgiQuest Announces First Single Port Procedure for Uterus and Ovary Removal Using AirSeal(TM) Access System 2Health News:Pharmacy Benefits Academy Set for 2009 2Health News:Pharmacy Benefits Academy Set for 2009 3Health News:Glowing Substance Lights Up Cancer in Mice 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: